News & Info


Page 19 of 29« First...10...1718192021...Last »

April 22, 2012

IL-18 Can Prevent Inflammation in the Retina

Posted in: Research and Developments

by Dan Roberts Updated April 2014 A new finding by researchers at Trinity College Dublin may lead to another treatment for wet AMD. Inflammation in the retina results from blood vessel development, and the natural component named IL-18 has been found to keep the process under control. By injecting the chemical into the eye, or
read more »

March 11, 2012

What Is Macular Degeneration?

Posted in: Daily Living, Eye Conditions, Health and Nutrition, Low Vision Rehabilitation, Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts (Updated April 29, 2015) (Reviewed by Martin A. Mainster, Ph.D., M.D., FRCOphth) Audio/visual presentations on all related subjects Recommended books: The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas Mogk, M.D.
read more »

February 28, 2012

Fenretinide For Treatment of Dry MD and Stargardt’s Disease

Posted in: Research and Developments

by Dan Roberts (Updated February 28, 2012) Fenretinide (RT-101), a drug that has been used to treat certain cancers, rheumatoid arthritis, acne, and psoriasis, has been found to also slow the production and accumulation of a toxin that leads to vision loss in Stargardt’s patients. The toxin, called A2E, is a byproduct of vitamin A,
read more »

February 9, 2012

New Radiation Treatment for Wet AMD

Posted in: Research and Developments

by Dan Roberts [It was reported on 2/9/12 that Phase III of this study did not meet it’s primary endpoint at 2 years. The information in this article describes the progress up to that point.] NeoVista, Inc. announced on June 17, 2007 the official commencement of the CABERNET (Cnv secondary to Amd treated with BEta
read more »

February 2, 2012

New Treatment for Dry AMD Using HuCNS Stem Cells

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts February 2, 2012 StemCells, Inc. announced on February 2, 2012 that the FDA has authorized a Phase I/II clinical trial of a new method using stem cells from the brain to prevent degeneration of the macula in dry AMD patients. Purified human neural stem cells (HuCNS-SC) will be administered by a single
read more »

December 12, 2011

Degenerative Myopia: a Review of its Nature and Current Treatment

Posted in: Eye Conditions

by Brian Ward, Ph.D., M.D. December 2011 Degenerative myopia deserves our recognition as one of the truly neglected areas of ophthalmology. It is reported to be the seventh ranking cause of legal blindness in the United Sates of America the fourth ranking cause in Hong Kong and the second in parts of China and Japan.
read more »

November 15, 2011

An Examination of Sensory Contributions to Independent Activities of Daily Living

Posted in: Daily Living

This paper is in PDF format. To download it, select this link.

October 3, 2011

Artificial Lighting and the Blue Light Hazard

Posted in: Daily Living

(The Facts About Lighting and Vision) by Dan Roberts, Founding Director Macular Degeneration Support Originally published on MDSupport, updated October 3, 2011) Contents Introduction What Is Light? The Blue Light Hazard Terms Referring to Measurement of Light Types of Lamps The Problem With Full-Spectrum Lamps Market Survey Summary Discussion Safe Options Live Comparison of Representative
read more »

June 1, 2011

AMD Report From ARVO 2011

Posted in: Research and Developments

by Dan Roberts It is important to note at the outset of this report that patients are highly respected across the professional board for their willingness to act as pioneers in the ongoing research. Our participation in clinical trials is greatly appreciated by the researchers. That having been said, here are latest updates on research
read more »

June 1, 2011

Summary of Research and Developments in Macular Degeneration, 2010-2011

Posted in: Research and Developments

by Dan Roberts June 19, 2011 Introduction Since 2006, I have done my best to condense the high points of the previous year’s macular degeneration research into a single report that is concise and understandable for the layperson. I do so, because I understand first hand how important it is to be aware of everything
read more »

May 30, 2011

Encapsulated Cell Technology (ECT)–A New Drug Delivery System

Posted in: Research and Developments

by Dan Roberts Updated March 30, 2015 A means of delivering drugs into the retina on a time release basis is being developed and proven safe and effective. It is achieved by a method called Encapsulated Cell Technology (ECT), being tested by Neurotech SA with support from the National Eye Institute (NEI), Bethesda, Maryland. A
read more »

May 25, 2011

Stargardt Disease

Posted in: Eye Conditions

by Dan Roberts (Updated May 25, 2011) Stargardt disease (also known as fundus flavimaculatus and Stargardt macular dystrophy) is the most common form of inherited juvenile macular degeneration. Inherited as an autosomal recessive trait, it is a severe form of MD that begins in late childhood, leading to legal blindness. Stargardt disease is symptomatically similar
read more »

May 13, 2011

Ten Things to Know About Multivitamins

Posted in: Health and Nutrition

by Ellen Troyer CEO & Chief Research Officer Biosyntrx Nutritional Technology May 13, 2011 It’s easy to become confused with so many multivitamins choices available. To help sort out the facts, here are ten things eye doctors and their patients should look for when recommending or selecting an ocular health/full-body multivitamin supplement. 1. Both eye
read more »

April 22, 2011

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Posted in: Research and Developments

The CATT Research Group April 2011 In 2005, clinical trials established the efficacy of ranibizumab (Lucentis, Genentech) for the treatment of neovascular age-related macular degeneration (AMD), the leading cause of legal blindness in the United States. While awaiting approval for ranibizumab from the Food and Drug Administration, ophthalmologists began treating neovascular AMD with off-label use
read more »

March 1, 2011

Maintaining Independence and Quality of Life

Posted in: Daily Living, Latest News, Low Vision Rehabilitation

by Dan Roberts March 2011 The “English Longitudinal Study of Ageing” has found that people with poor eyesight are three to five times more likely than those with good eyesight to suffer from low quality of life, poor psychological health, and depression.1 When those inequalities are accounted for, however, the impact of poor eyesight itself
read more »

Page 19 of 29« First...10...1718192021...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann